Cargando…
Early glottic cancer treatment with concurrent chemoradiotherapy with once-daily orally administered S-1
Glottic carcinoma is the most common laryngeal cancer. The outcomes for T1 bulky Glottic carcinoma and T2N0 Glottic carcinoma after radiation therapy alone are unsatisfactory. This study was conducted to evaluate the efficacy and safety of unique concurrent chemoradiotherapy regimen using S-1 for ea...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nagoya University
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236680/ https://www.ncbi.nlm.nih.gov/pubmed/34239173 http://dx.doi.org/10.18999/nagjms.83.2.251 |